FamiCord Investor Relations Material
Latest events
Q1 2025
28 May, 2025
Q4 2024
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from FamiCord AG
Access all reports
FamiCord AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company also manufactures and sells reagents for bone marrow diagnostics. Its products include frozen cord blood units, partal bio-banking, culture and expansion f IMR90 K1, hematopoietic stem cells, adult progenitor cells, endothelial progenitor cells Mitomycin C; Vitapur; Vitafrost; Vitastem ampoules; sweet-hand sterilization bags for various applications; freezing bag for ten freezing bags; and pipette with tips. The company was founded in 1997 and is headquartered in Leipzig, Germany.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
V3V
Country
🇩🇪 Germany